A Day Late In Oakland prilosec carnitine interaction brush b gone ortho effects of zocor chuck soma long term phentermine use drinking on paroxetine deficient and testosterone marijuana senior citizens medical effects of opium smoking drug generic online pharmacy...
Crab Feed To Raise Funds For Senior Center Owens expects about 150 people to attend the event on November 1, at the South Berkeley Senior Center, 4:30 to 8:30.Tickets are $35.
and going, so people are advised to get their reservation in early.
Call (510) 981-5170.
Funds...
7th Annual Charlotte Biotechnology Conference to Feature Dr. Roger Newton, co-discoverer of Lipitor and Founde CHARLOTTE, N.C., Oct.1, 2008--( BUSINESS WIRE)--The University of North Carolina at Charlotte and the Charlotte Research Institute will present the 7th Annual Charlotte Biotechnology Conference (www.CharlotteBiotechnology.com) taking...
Surgical sponges grow for Pfizer Lipitor and Viagra are the best-known drugs made by Pfizer Inc.But Gelfoam, a hospital surgical product made in Michigan, has been a revenue-producer for the company for more than 50 years.
Now, Pfizer is looking to Gelfoam, a...
Surgical sponges grow for Pfizer Lipitor and Viagra are the best-known drugs made by Pfizer Inc.But Gelfoam, a hospital surgical product made in Michigan, has been a revenue-producer for the company for more than 50 years.
Now, Pfizer is looking to Gelfoam, a...
Surgical sponges grow for Pfizer: Gelfoam a longtime revenue producer (Detroit Free Press - McClatchy-Tribune Information Services via COMTEX) -- PFE | Quote | Chart | News | PowerRating -- Lipitor and Viagra are the best-known drugs made by Pfizer Inc.But Gelfoam, a hospital surgical product made in...
Pfizer narrows research focus again Pfizer is shifting its research focus to those diseases where its sees the potential for the biggest treatment improvements and profits, while dropping eight disease areas including cholesterol.The refocusing effort will not affect drug...
Is Pfizer the Mystery Bidder? Everyone wants to know who the mystery bidder is that's willing to go out on a limb to buy ImClone Systems (Nasdaq: IMCL) at $70 per share.Especially when the company's longtime partner, Bristol-Myers Squibb (NYSE: BMY), isn't willing to...
Surgical sponges grow for Pfizer Lipitor and Viagra are the best-known drugs made by Pfizer Inc.But Gelfoam, a hospital surgical product made in Michigan, has been a revenue-producer for the company for more than 50 years.
Now, Pfizer is looking to Gelfoam, a...
Cholesterol-Lowering Drug Linked to Amnesia I have normal LDL cholesterol but low HDL, as low as 26.With diet and exercise I can get my HDL to the mid-thirties, which is not great.
Lipitor lowered my LDL below 80 but sadly my HDL didnt budge.After being on Lipitor for...
A bitter pill to swallow While the worlds attention is focused on the mortgage industry, another major U.S.industry is facing troubles of its own.
The pharmaceutical industry has received a negative outlook from Moodys Investor Services and analysts believe the...
Pfizer narrows research focus again Email this page Print in friendly format News by email Your comments Keywords Latest news headlines Pfizer is shifting its research focus to those diseases where its sees the potential for the biggest treatment improvements and profits,...
Is it Lilly? ImClone Stays Mum on Mystery Big Pharma Bidder With two blockbuster products set to lose patent protection in the next two to three years, Eli Lilly and Co.certainly seems like a firm that would be willing to pay $70 per share - about $6.1 billion - to acquire ImClone Systems Inc.,...
Is it Lilly? ImClone Stays Mum on Mystery Big Pharma Bidder With two blockbuster products set to lose patent protection in the next two to three years, Eli Lilly and Co.certainly seems like a firm that would be willing to pay $70 per share - about $6.1 billion - to acquire ImClone Systems Inc.,...
Pfizer fights for its future In just 18 months, Pfizer Global Manufacturing (PGM) Puerto Rico has achieved its seemingly impossible goals: to cut its operational costs by 40% and to reduce its product-cycle times by 75%.This transformation is in response to a...
Pfizer upbeat on R&D progress pace BOSTON (MarketWatch) -- Pfizer Inc., which has faced chronic erosion of its top line due to increased competition from generic drugs, announced Tuesday that its research and development efforts to fill its pipeline are running ahead of...
Full Article Atherosclerotic vascular diseases are the leading cause of mortality and morbidity in the Western world.The most important modifiable risk factor, partly influenced by genetics and partly by lifestyle factors, is dyslipidemia.
Since...
Pfizer narrows research focus again Pfizer is shifting its research focus to those diseases where its sees the potential for the biggest treatment improvements and profits, while dropping eight disease areas including cholesterol.The refocusing effort will not affect drug...
7th Annual Charlotte Biotechnology Conference to feature Dr. Roger Newton, co-discoverer of Lipitor(R) and fou - The University of North Carolina at Charlotte and the Charlotte Research Institute will present the 7th Annual Charlotte Biotechnology Conference (www.CharlotteBiotechnology.com) taking place at the Barnhardt Student Activities Center on...
Please comrade, join the queue Sensation!More news by category: Bromocriptine Pravastatin Levoxyl Klonopin vs xanax dosage Tramadol hcl Bulk phentermine Drug interaction sibutramine and phentermine L arginine natural viagra Cyclothiazide Probucol Viagra substitutes...
Pfizer alters focus in rush for new drugs NEW YORK - Pfizer Inc.will abandon early stage research on heart drugs as part of a strategy to sharpen its focus on ailments such as cancer, Alzheimer's disease, and diabetes where the chances of a bigger profit are greatest.The New York...
Pfizer To Shift R&D Focus Pfizer will discontinue development of drugs for heart disease, obesity and bone health as part of its plan to focus research on Alzheimer's disease, diabetes, inflammation/immunology, oncology, pain and psychoses (schizophrenia), according...
Pharma giant Pfizer shifts focus to cancer and biotech drugs TRENTON, N.J., Pfizer Inc.is shifting its research focus to diseases that have high potential for treatment improvements, such as cancer and Alzheimer's disease, and where it can be a market leader.
The world's biggest drug maker also...
Pharma giant Pfizer shifts focus to cancer and biotech drugs TRENTON, N.J., Pfizer Inc.is shifting its research focus to diseases that have high potential for treatment improvements, such as cancer and Alzheimer's disease, and where it can be a market leader.
The world's biggest drug maker also...
Lipitor dispute settled Skip to main contentSkip to Navigation menu Skip to Login form Navigation Menu Skip to main contentSkip to top of page Change font size: Browse by Sector Browse by Section IP Resources Other Services Skip to Navigation menuSkip to top of...
